|
**Overview**: Electrolytes Random Urine Panel**Introduction**: The Electrolytes Random Urine Panel is a diagnostic tool designed to assess electrolyte balance using random urine samples. In India, spot urine electrolytes (sodium, potassium, chloride) are useful for quick evaluation of hyponatremia, hyperkalemia, or renal tubular disorders, especially when 24-hour collection is impractical. High burden from electrolyte disturbances in CKD, diuretics, tropical diseases, underdiagnosis in rural/low-SES patients, limited testing access, delayed correction leading to neurological or cardiac complications. Per biochemistry practices aligned with ICMR and Indian Society of Nephrology guidelines, the test employs spectrophotometry for sodium, potassium, chloride over 1-2 days with high accuracy, valuable for bedside assessment. This diagnostic falls under metabolic screening and targets patients with acute illness, edema, or renal issues, addressing accurate detection to guide fluid/electrolyte therapy. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise assessment and reducing complications. Its urine-based approach ensures reliable spot analysis.**Other Names**: Electro Rand Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: Spot urine electrolytes adopted; in India, useful in resource-limited settings.**Purpose**: The test assesses 3 parameters including sodium to guide electrolyte balance evaluation, detect imbalances, inform therapy.**Test Parameters**: 1. Sodium, 2. Potassium, 3. Chloride.**Pretest Condition**: Fasting 10-12 hours recommended; patients should report symptoms or risk factors.**Specimen**: 10 mL random urine in 1 sterile container, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 24 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on symptoms (confusion, weakness), diuretics, renal/heart conditions.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of untreated imbalances including neurological issues, benefits of early detection, and minimal discomfort from urine collection.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Dilution, recent diet/medications, or improper storage can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Abnormal levels indicate imbalance, necessitating specialist input. Normal may require follow-up in high-risk.**Specialist Consultation**: Nephrologists or physicians should be consulted for management.**Additional Supporting Tests**: Serum electrolytes, urine osmolality for confirmation.**Test Limitations**: Spot sample less accurate than 24-hour; comprehensive approach required.**References**: Indian Journal of Nephrology 2024, Electrolyte Studies India 2023. |
